KRISTI MILLER: Open Payments
NPI 1831794981 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 41 payments from 18 companies in 2025. Trend: 2023 $675 · 2024 $704 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $489 |
| ABBVIE INC. | 3 | $226 |
| Kowa Pharmaceuticals America, Inc. | 4 | $146 |
| Abbott Laboratories | 1 | $128 |
| Otsuka America Pharmaceutical, Inc. | 2 | $128 |
| Lilly USA, LLC | 1 | $125 |
| Novo Nordisk Inc | 2 | $121 |
| Inspire Medical Systems, Inc. | 2 | $66 |
| Exact Sciences Corporation | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: VRAYLAR, BREZTRI, ZORYVE, AIRSUPRA, FREESTYLE LIBRE 3, REXULTI, FARXIGA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
